Ubiquitination of RORγt at lysine 446 limits Th17 differentiation by controlling coactivator recruitment

Journal of Immunology

Volumn 197, Issue 4, 2016, Pages 1148-1158

  He, Zhiheng ^a   Wang, Fei ^a   Ma, Jian ^a   Sen, Subha ^a   Zhang, Jing ^a,b   Gwack, Yousang ^c   Zhou, Yu ^d   Sun, Zuoming ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b Irell and Manella Graduate School of Biological Sciences   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DEUBIQUITINASE; LYSINE; STEROID RECEPTOR COACTIVATOR 1; NCOA1 PROTEIN, MOUSE; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RORC PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE MUTATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RORGAMMAT GENE; SIGNAL TRANSDUCTION; TH17 CELL; UBIQUITINATION; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; METABOLISM; POLYMERASE CHAIN REACTION;

ANIMALS; CELL DIFFERENTIATION; FLOW CYTOMETRY; IMMUNOPRECIPITATION; LYSINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEAR RECEPTOR COACTIVATOR 1; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; POLYMERASE CHAIN REACTION; TH17 CELLS; UBIQUITINATION;

EID: 84983802006     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600548     Document Type: Article

References (57)

1. Wang, Z., C. Friedrich, S. C. Hagemann, W. H. Korte, N. Goharani, S. Cording, G. Eberl, T. Sparwasser, and M. Lochner. 2014. Regulatory T cells promote a protective Th17-associated immune response to intestinal bacterial infection with C. rodentium. Mucosal Immunol. 7: 1290-1301.
2. Basu, R., S. K. Whitley, S. Bhaumik, C. L. Zindl, T. R. Schoeb, E. N. Benveniste, W. S. Pear, R. D. Hatton, and C. T. Weaver. 2015. IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance. Nat. Immunol. 16: 286-295.
3. Esplugues, E., S. Huber, N. Gagliani, A. E. Hauser, T. Town, Y. Y. Wan, W. O'Connor Jr., A. Rongvaux, N. Van Rooijen, A. M. Haberman, et al. 2011. Control of TH17 cells occurs in the small intestine. Nature 475: 514-518.
4. Elloso, M. M., M. Gomez-Angelats, and A. M. Fourie. 2012. Targeting the Th17 pathway in psoriasis. J. Leukoc. Biol. 92: 1187-1197.
5. Johnson-Huang, L. M., M. A. Lowes, and J. G. Krueger. 2012. Putting together the psoriasis puzzle: An update on developing targeted therapies. Dis. Model. Mech. 5: 423-433.
6. Ivanov, I. I., B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, and D. R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
7. Ciofani, M., A. Madar, C. Galan, M. Sellars, K. Mace, F. Pauli, A. Agarwal, W. Huang, C. N. Parkurst, M. Muratet, et al. 2012. A validated regulatory network for Th17 cell specification. Cell 151: 289-303.
8. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441: 231-234.
9. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
10. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
11. Chung, Y., S. H. Chang, G. J. Martinez, X. O. Yang, R. Nurieva, H. S. Kang, L. Ma, S. S. Watowich, A. M. Jetten, Q. Tian, and C. Dong. 2009. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576-587.
12. Sutton, C., C. Brereton, B. Keogh, K. H. Mills, and E. C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203: 1685-1691.
13. Okada, S., J. G. Markle, E. K. Deenick, F. Mele, D. Averbuch, M. Lagos, M. Alzahrani, S. Al-Muhsen, R. Halwani, C. S. Ma, et al. 2015. IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science 349: 606-613.
14. Ratajewski, M., A. Walczak-Drzewiecka, A. Salkowska, and J. Dastych. 2012. Upstream stimulating factors regulate the expression of RORgT in human lymphocytes. J. Immunol. 189: 3034-3042.
15. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 cells. Annu. Rev. Immunol. 27: 485-517.
16. Gaffen, S. L., R. Jain, A. V. Garg, and D. J. Cua. 2014. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14: 585-600.
17. Codarri, L., G. Gyuulvészi, V. Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter, and B. Becher. 2011. RORyt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12: 560-567.
18. El-Behi, M., B. Ciric, H. Dai, Y. Yan, M. Cullimore, F. Safavi, G. X. Zhang, B. N. Dittel, and A. Rostami. 2011. The encephalitogenicity of T(H)17 cells is dependent on IL-1- And IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12: 568-575.
19. Yang, J., M. S. Sundrud, J. Skepner, and T. Yamagata. 2014. Targeting Th17 cells in autoimmune diseases. Trends Pharmacol. Sci. 35: 493-500.
20. Huh, J. R., and D. R. Littman. 2012. Small molecule inhibitors of RORgt: Targeting Th17 cells and other applications. Eur. J. Immunol. 42: 2232-2237.
21. Skepner, J., R. Ramesh, M. Trocha, D. Schmidt, E. Baloglu, M. Lobera, T. Carlson, J. Hill, L. A. Orband-Miller, A. Barnes, et al. 2014. Pharmacologic inhibition of RORgt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo. J. Immunol. 192: 2564-2575.
22. Xiao, S., N. Yosef, J. Yang, Y. Wang, L. Zhou, C. Zhu, C. Wu, E. Baloglu, D. Schmidt, R. Ramesh, et al. 2014. Small-molecule RORgt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms. Immunity 40: 477-489.
23. Sheridan, C. 2013. Footrace to clinic heats up for T-cell nuclear receptor inhibitors. Nat. Biotechnol. 31: 370.
24. Huang, Z., H. Xie, R. Wang, and Z. Sun. 2007. Retinoid-related orphan receptor gamma t is a potential therapeutic target for controlling inflammatory autoimmunity. Expert Opin. Ther. Targets 11: 737-743.
25. He, Y. W., M. L. Deftos, E. W. Ojala, and M. J. Bevan. 1998. RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity 9: 797-806.
26. Ortiz, M. A., F. J. Piedrafita, M. Pfahl, and R. Maki. 1995. TOR: A new orphan receptor expressed in the thymus that can modulate retinoid and thyroid hormone signals. Mol. Endocrinol. 9: 1679-1691.
27. Xie, H., Z. Huang, R. Wang, and Z. Sun. 2006. Regulation of thymocyte survival by transcriptional coactivators. Crit. Rev. Immunol. 26: 475-486.
28. Xie, H., M. S. Sadim, and Z. Sun. 2005. RORgammat recruits steroid receptor coactivators to ensure thymocyte survival. J. Immunol. 175: 3800-3809.
29. Walsh, C. A., L. Qin, J. C. Tien, L. S. Young, and J. Xu. 2012. The function of steroid receptor coactivator-1 in normal tissues and cancer. Int. J. Biol. Sci. 8: 470-485.
30. Santori, F. R., P. Huang, S. A. van de Pavert, E. F. Douglass Jr., D. J. Leaver, B. A. Haubrich, R. Keber, G. Lorbek, T. Konijn, B. N. Rosales, et al. 2015. Identification of natural RORg ligands that regulate the development of lymphoid cells. Cell Metab. 21: 286-297.
31. Yosef, N., A. K. Shalek, J. T. Gaublomme, H. Jin, Y. Lee, A. Awasthi, C. Wu, K. Karwacz, S. Xiao, M. Jorgolli, et al. 2013. Dynamic regulatory network controlling TH17 cell differentiation. Nature 496: 461-468.
32. Komander, D., and M. Rape. 2012. The ubiquitin code. Annu. Rev. Biochem. 81: 203-229.
33. Reyes-Turcu, F. E., K. H. Ventii, and K. D. Wilkinson. 2009. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu. Rev. Biochem. 78: 363-397.
34. Rutz, S., N. Kayagaki, Q. T. Phung, C. Eidenschenk, R. Noubade, X. Wang, J. Lesch, R. Lu, K. Newton, O. W. Huang, et al. 2015. Deubiquitinase DUBA is a posttranslational brake on interleukin-17 production in T cells. Nature 518: 417-421.
35. Han, L., J. Yang, X. Wang, Q. Wu, S. Yin, Z. Li, J. Zhang, Y. Xing, Z. Chen, A. Tsun, et al. 2014. The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor gt (RORgt) in Th17 cells. J. Biol. Chem. 289: 25546-25555.
36. Wang, X., J. Yang, L. Han, K. Zhao, Q. Wu, L. Bao, Z. Li, L. Lv, and B. Li. 2015. TRAF5-mediated Lys-63-linked Polyubiquitination Plays an Essential Role in Positive Regulation of RORgt in Promoting IL-17A Expression. J. Biol. Chem. 290: 29086-29094.
37. Yang, J., P. Xu, L. Han, Z. Guo, X. Wang, Z. Chen, J. Nie, S. Yin, M. Piccioni, A. Tsun, et al. 2015. Cutting edge: Ubiquitin-specific protease 4 promotes Th17 cell function under inflammation by deubiquitinating and stabilizing RORgt. J. Immunol. 194: 4094-4097.
38. Sun, Z., D. Unutmaz, Y. R. Zou, M. J. Sunshine, A. Pierani, S. Brenner-Morton, R. E. Mebius, and D. R. Littman. 2000. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 288: 2369-2373.
39. Borodovsky, A., H. Ovaa, N. Kolli, T. Gan-Erdene, K. D. Wilkinson, H. L. Ploegh, and B. M. Kessler. 2002. Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem. Biol. 9: 1149-1159.
40. Hjerpe, R., F. Aillet, F. Lopitz-Otsoa, V. Lang, P. England, and M. S. Rodriguez. 2009. Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO Rep. 10: 1250-1258.
41. Miller, M. J., G. A. Barrett-Wilt, Z. Hua, and R. D. Vierstra. 2010. Proteomic analyses identify a diverse array of nuclear processes affected by small ubiquitinlike modifier conjugation in Arabidopsis. Proc. Natl. Acad. Sci. U S A 107: 16512-16517.
42. Wang, X., Y. Zhang, X. O. Yang, R. I. Nurieva, S. H. Chang, S. S. Ojeda, H. S. Kang, K. S. Schluns, J. Gui, A. M. Jetten, and C. Dong. 2012. Transcription of Il17 and Il17f is controlled by conserved noncoding sequence 2. Immunity 36: 23-31.
43. Ichiyama, K., H. Yoshida, Y. Wakabayashi, T. Chinen, K. Saeki, M. Nakaya, G. Takaesu, S. Hori, A. Yoshimura, and T. Kobayashi. 2008. Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat. J. Biol. Chem. 283: 17003-17008.
44. Hetfeld, B. K., A. Helfrich, B. Kapelari, H. Scheel, K. Hofmann, A. Guterman, M. Glickman, R. Schade, P. M. Kloetzel, and W. Dubiel. 2005. The zinc finger of the CSN-associated deubiquitinating enzyme USP15 is essential to rescue the E3 ligase Rbx1. Curr. Biol. 15: 1217-1221.
45. Zelante, T., A. De Luca, C. D'Angelo, S. Moretti, and L. Romani. 2009. IL-17/Th17 in anti-fungal immunity: What's new? Eur. J. Immunol. 39: 645-648.
46. van de Veerdonk, F. L., R. J. Marijnissen, B. J. Kullberg, H. J. Koenen, S. C. Cheng, I. Joosten, W. B. van den Berg, D. L. Williams, J. W. van der Meer, L. A. Joosten, and M. G. Netea. 2009. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 5: 329-340.
47. Lee, Y., A. Awasthi, N. Yosef, F. J. Quintana, S. Xiao, A. Peters, C. Wu, M. Kleinewietfeld, S. Kunder, D. A. Hafler, et al. 2012. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13: 991-999.
48. Dasgupta, S., D. M. Lonard, and B. W. O'Malley. 2014. Nuclear receptor coactivators: master regulators of human health and disease. Annu. Rev. Med. 65: 279-292.
49. Zou, Q., J. Jin, H. Hu, H. S. Li, S. Romano, Y. Xiao, M. Nakaya, X. Zhou, X. Cheng, P. Yang, et al. 2014. USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. Nat. Immunol. 15: 562-570.
50. Herhaus, L., M. A. Al-Salihi, K. S. Dingwell, T. D. Cummins, L. Wasmus, J. Vogt, R. Ewan, D. Bruce, T. Macartney, S. Weidlich, et al. 2014. USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling. Open Biol. 4: 140065.
51. Vos, R. M., J. Altreuter, E. A. White, and P. M. Howley. 2009. The ubiquitinspecific peptidase USP15 regulates human papillomavirus type 16 E6 protein stability. J. Virol. 83: 8885-8892.
52. Faronato, M., V. Patel, S. Darling, L. Dearden, M. J. Clague, S. Urbe, and J. M. Coulson. 2013. The deubiquitylase USP15 stabilizes newly synthesized REST and rescues its expression at mitotic exit. Cell Cycle 12: 1964-1977.
53. Eichhorn, P. J., L. Rodón, A. Gonzàlez-Juncà, A. Dirac, M. Gili, E. Martínez- Sáez, C. Aura, I. Barba, V. Peg, A. Prat, et al. 2012. USP15 stabilizes TGF-b receptor I and promotes oncogenesis through the activation of TGF-b signaling in glioblastoma. Nat. Med. 18: 429-435.
54. Tonel, G., C. Conrad, U. Laggner, P. Di Meglio, K. Grys, T. K. McClanahan, W. M. Blumenschein, J. Z. Qin, H. Xin, E. Oldham, et al. 2010. Cutting edge: A critical functional role for IL-23 in psoriasis. J. Immunol. 185: 5688-5691.
55. Segal, B. M., C. S. Constantinescu, A. Raychaudhuri, L. Kim, R. Fidelus-Gort, L. H. Kasper, and M. S. I. Ustekinumab, Ustekinumab MS Investigators. 2008. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: A phase II, double- blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol. 7: 796-804.
56. Benson, J. M., D. Peritt, B. J. Scallon, G. A. Heavner, D. J. Shealy, J. M. Giles- Komar, and M. A. Mascelli. 2011. Discovery and mechanism of ustekinumab: A human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders. MAbs 3: 535-545.
57. Feng, A. P., Y. M. He, X. X. Liu, J. W. Li, Y. T. Tu, F. Hu, and S. J. Chen. 2014. Expression of USP15, TbetaR-I and Smad7 in psoriasis. J. Huazhong Univ. Sci. Technolog. Med. Sci. 34: 415-419.